Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 16, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
Study demonstrate a dependency on gut bacteria for strong immune responses to the seasonal flu and inactivated polio vaccines.
Novel Immunotherapy Breast Cancer Vaccine
Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients.
Cell ‘Memory’ Could be Key to Strengthen Vaccine Efficacy
Virginia Tech Carilion Research Institute scientists uncover immune system secret.
NIH-Led Scientists Discover HIV Antibody that Binds to Novel Target on Virus
The antibody, 35O22, prevents 62 percent of known HIV strains from infecting cells in the laboratory.
Breakthrough Melanoma Treatment, Keytruda, Developed
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.
Understanding and Improving the Body's Fight Against Pathogens
A*STAR scientists find new targets for modulating antibody response.
NIH to Launch Human Safety Study of Ebola Vaccine Candidate
Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines.
MU Researchers Discover Protein's Ability To Inhibit HIV Release
TIM-family proteins have the ability to block the release of HIV and other viruses.
High Capacity Antibody Purification
Researchers from the A*Star Bioprocessing Technology Institute have used magnetic nanoparticles to break the capacity barrier for antibody purification.
Experimental Chikungunya Vaccine Induces Robust Antibody Response
Vaccine developed by NIH scientists performs well in early clinical trial.

Continuous Chromatography (MCSGP) for the Purification of Therapeutic Proteins
Dr Thomas Müller-Späth, ETH Switzerland, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Biosimilars and the US-legislation: Analytical and Clinical Challenges
Dr William Egan, Vice President in the Consulting Division of PharmaNet, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Actionable Biomarkers for Rheumatoid Arthritis
Dr William Robinson, Stanford University, speaking at Microarray World Congress 2011.

Background and Key Drivers Leading to Clinical Immunogenicity
Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.

Thinking Small so as to Gain the Bigger Picture: Progress in High Throughput Bioprocess Development
Professor Nigel Titchener-Hooker, University College London, speaking at Bioprocessing, Biologics and Biotherapeutics Congress 2011.

Antibody Fragments - New Approaches for Production
Dr John Lidell, FujiFilm, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

EU Regulatory Landscape for Approval of Biosimilars
Dr Lincoln Tsang, Arnold and Porter LLP, speaking at BioProcessing, Biologics & Biotherapeutics Congress / Stem Cells Europe 2011.

Modeling and Prediction of Antibody Chromatography Purification
Professor Christian Frech, Mannheim University of Applied Science, speaking at BioProcessing, Biologics and Biotherapeutics Congress.

Host Cell Protein Interactions During the Recovery of Monoclonal Antibodies
Dr Daniel Bracewell, University College London, speaking at BioProcessing, Biologics and Biotherapeutics Congress 2011.

<< 1 2 3 >>
Showing Results 21 - 30 of 30
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv